Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN105481703A enables high-purity S-2-aminobutanol via catalytic hydrogenation. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102807560A reveals asymmetric oxidation method. Achieves high purity and yield. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102850319A reveals a cost-effective, high-yield route for Fingolimod intermediates, eliminating toxic solvents and expensive palladium catalysts for scalable manufacturing.
Patent CN102816083B reveals high-purity Lacosamide intermediate synthesis with strict temperature control and improved yield for reliable supply chain.
Novel patent CN105061234A offers high-purity pregabalin route. Reduces costs and improves supply chain reliability for pharmaceutical intermediate manufacturing globally.
Patent CN103288708A reveals a mild, cost-effective route for 1-aryl-2-indolinone derivatives, offering significant supply chain advantages for API manufacturing.
Patent CN1884284A details a high-yield Faropenem Sodium process using L-Threonine. Discover cost-effective API intermediate manufacturing and supply chain advantages.
This report analyzes patent CN104892539A for iron-catalyzed synthesis. It offers safety and cost advantages for pharmaceutical intermediate supply chains globally.
Novel L-Threonine based route for Faropenem Sodium. Eliminates heavy metals, reduces cost, ensures high purity. Ideal for API manufacturing scale-up.
Patent CN100506789C reveals high-yield sulfonation method. Enhances supply chain reliability and reduces manufacturing costs for global buyers.
Patent CN106854182B reveals a high-yield, one-pot synthesis for 2,5-dichloro-N-(2-(isopropylsulfonyl)phenyl)pyrimidin-4-amine, offering significant cost reduction in API manufacturing.
Patent CN104630242B reveals novel biocatalytic routes for chiral intermediates. Enhances supply chain reliability and reduces heavy metal dependency in manufacturing.
Patent CN115772103B reveals mild catalytic oxidation for sulfoxides. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN121248673A details (2S)-UNA monomer synthesis enabling 5-prime to 3-prime oligonucleotide assembly with enhanced stability and supply chain reliability.
Novel patent CN115181147B enables high-purity nucleoside intermediates with streamlined synthesis for cost-effective pharmaceutical manufacturing supply chains.
Patent CN101024631A reveals a novel telmisartan intermediate synthesis. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Advanced preparation method for S-1-(4-ethoxybenzyl)-3-azapentane-1,5-diamine trihydrochloride. Safe, high-yield route for MRI contrast agent intermediates ensuring cost reduction and supply stability.
Patent CN117089533A details novel carbonyl reductase mutants enabling cost reduction in chiral alcohol manufacturing with high stereoselectivity and supply reliability.
Patent CN114907234A reveals a safer, cost-effective route for 2-fluoro-5-formylbenzonitrile, eliminating toxic reagents for scalable Olaparib intermediate manufacturing.
High purity NAG synthesis via chitin hydrolysis. Cost-effective, scalable process for pharma and nutrition supply chains.